America as we know it was built largely upon and because of our rail industry, and today it remains…
So-Called "Railway Safety Act" Constitutes a Political Handout to Big Labor That Does Nothing to Improve Safety At All
America as we know it was built largely upon and because of our rail industry, and today it remains a pillar of our economy.
Unfortunately, a destructive proposal before Congress misleadingly named the "Railway Safety Act" (RSA), part of broader surface transportation reauthorization, threatens great harm to our railroads.
Simply put, the bill has nothing to do with improving safety, but has a lot to do with advancing the political agenda of Big Labor. At a moment when inflation burdens American families and fragile supply chains remain vulnerable to disruption, the last thing our economy or rail sector need is another costly federal mandate imposed upon one of the nation’s most important transportation sectors.
As an initial matter, as noted by The Wall Street Journal, the…[more]
Sally Pipes, President and CEO at the Pacific Research Institute, discusses how President Biden's drug price controls undermine his Cancer Moonshot initiative, and the ultimate impact price controls will have on patient lives, innovation, and research and development.
Sally Pipes, President and CEO of Pacific Research Institute, discusses her recently released book, “The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy and How to Keep It,” the horrible impacts of price controls, how single-payer healthcare systems fail children and cancer patients, and more.
Sally Pipes, Founder and President of Pacific Research Institute, discusses the impact of drug price controls under the Inflation Reduction Act (IRA), what it means for research and development of life-saving medicines, and how the IRA's drug pricing provisions will reduce access to new cures and treatments and result in longer wait times for existing medicines.
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.
Sally Pipes, President and CEO of Pacific Research Institute, discusses the likely disastrous effects of drug price control provisions contained in the Inflation Reduction Act and why Congress should embrace a free-market vision when it comes to healthcare by lowering taxes, encouraging innovation and expanding access.
Phil Kerpen, Founder and President of American Commitment, discusses provisions regarding drug price controls that are contained in the so-called "Inflation Reduction Act" that will negatively impact American's access to necessary drugs and harm innovation, and why the legislation may be unconstitutional.
Timothy Lee, CFIF's Senior Vice President of Legal and Public Affairs, discusses the potential real world costs of prescription drug price controls, including lost lives, shortages and innovation disincentives, and how drug prices are weathering the inflation storm.